Sign up to save your podcasts
Or
Share The DEA’s Adjustment to Schedule II Rules Amid COVID-19
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
Host: Linda Bernstein, Pharm.D.
The Drug Enforcement Administration (DEA) issued a new guidance for the issuance of oral Schedule II prescriptions in light of the COVID-19 pandemic and nationwide public health emergency. Pharmacist Dr. Linda Bernstein details the DEA’s temporary exceptions to the regulations to ease prescribing and dispensing of these controlled substances during this challenging time.
Published April 24, 2020
View all episodes
By ReachMDHost: Linda Bernstein, Pharm.D.
The Drug Enforcement Administration (DEA) issued a new guidance for the issuance of oral Schedule II prescriptions in light of the COVID-19 pandemic and nationwide public health emergency. Pharmacist Dr. Linda Bernstein details the DEA’s temporary exceptions to the regulations to ease prescribing and dispensing of these controlled substances during this challenging time.
Published April 24, 2020